Which Federal Laws Are on the MPJE?

The federal laws on the MPJE show up in NABP's outline as agencies and topics, not as statute titles. The new MPJE Content Outline, which governs exams administered on or after March 1, 2027, names the FDA, the DEA, the Drug Supply Chain Security Act (DSCSA), USP standards, OSHA and NIOSH, and lists controlled-substance topics such as inventory, record keeping, order forms, DEA registration and power of attorney, theft and loss, and disposal.

What it does not do is name the Controlled Substances Act or the Food, Drug, and Cosmetic Act by title. Those two statutes sit behind most of the federal items on the list, but that connection is our mapping. NABP never says it, and plenty of prep material talks as if it did.

Which federal laws on the MPJE does NABP's outline name?

As of October 2026, NABP publishes the new outline as a PDF alongside its MPJE Competency Statements page. Go to the PDF rather than someone's summary of it. The items below are the ones with a federal agency, federal standard or federal-flavored topic attached, quoted by outline number:

• 1.C "Adulterated or misbranded medications", with examples listed as medication recalls, expiration dates, counterfeit medications, emergency use authorizations, importation, and the DSCSA.

• 1.D "Regulatory standards", with examples listed as NIOSH, OSHA, the FDA, Board of Pharmacy regulations, and USP standards.

• 1.F "Security of patient health information".

• 2.A.1 "Validity of a prescription", with examples listed as authority, content, and corresponding responsibility.

• 2.A.3 "Emergency prescriptions and emergency refills".

• 2.B.7 "Prescription drug monitoring program (PDMP) requirements".

• 3.A.1 "Federal", with the FDA and the DEA as its examples, sitting directly beside 3.A.2 "State", with the board of pharmacy and department of health.

• 3.B "Controlled substances", broken into six subtopics: inventory; record keeping; order forms and ordering; DEA registration and power of attorney; theft and loss; and disposal.

Item 3.A is the only place in the outline that splits regulatory authority explicitly into a federal line and a state line. Apart from 1.E, which is headed "State-specific standards on compounding and hazardous materials", the other headings do not say which layer of law a question will draw on.

The list is short because an outline only tells you which topics a question can come from. What the rule in each topic says is left to you.

Does the outline name the big federal statutes?

No. Neither the Controlled Substances Act nor the Food, Drug, and Cosmetic Act appears by name anywhere in the MPJE Content Outline, and neither do HIPAA, the Combat Methamphetamine Epidemic Act, the Poison Prevention Packaging Act or OBRA. Anyone telling you "NABP lists the CSA as a tested statute" is putting words in NABP's mouth.

That does not make the statutes optional. A topic called "DEA registration and power of attorney" is a Controlled Substances Act topic whether the outline says so or not, because the DEA's authority over pharmacies comes from that act. The table maps NABP's items to the federal law we think sits behind each one. The middle column is our reading; NABP wrote only the first.

Look at the PDMP and USP rows. The PDMP row looks federal because it sits near controlled substances, but CDC describes a PDMP as a database that tracks controlled substance prescriptions "in a state", so expect your state's rules to drive this topic. The USP row is a category mistake waiting to happen: USP describes itself as a private, non-profit scientific organization that develops standards. It is not a regulator, even though NABP lists its standards next to the FDA and board regulations.

What if I test before the 2027 outline starts?

If you sit the MPJE on or before February 28, 2027, your exam is still built on the MPJE Competency Statements, with four areas weighted 22, 33, 24 and 21 percent. NABP's own banner on that page says the statements will be updated for exams administered starting March 1, 2027.

The Competency Statements name no federal statute by title either. They work at a higher level, with subareas such as 2.5 "Regulations and agencies regarding pharmacy practice", a line under 3.3 on "Requirements for reporting to PMP and accessing PMP data", and a line under 4.2 on "Requirements for conducting controlled substance inventories".

Our view: even before March 2027, the new outline is the better federal checklist. Both documents describe the exam as testing federal and state law. The newer one just names more of the federal ground explicitly, so it shows gaps in your preparation that the broader 2026 wording hides.

Why doesn't the MPJE label a question as federal or state?

Because NABP builds it not to. The Competency Statements page says, in NABP's words, "No distinction is made in the examination between federal and state jurisprudence questions." You answer each question under the prevailing laws of the state where you are seeking licensure.

That changes what "knowing the federal laws" means for this exam. Reciting that the DEA enforces the Controlled Substances Act earns nothing on its own. What earns points is knowing, inside a question that never announces its source, which layer of law controls the answer. NABP does not publish a federal versus state split, a point covered in how much of the MPJE is federal law. How the two layers interact, and how our books handle conflicts as a study technique, is in federal vs state law on the MPJE.

Where do candidates blur the federal topics?

Item 1.C is the first. It files recalls, expiration dates, counterfeit drugs, emergency use authorizations, importation and the DSCSA under one heading: adulterated or misbranded medications. Adulterated and misbranded are two different FDCA concepts, and they are easy to treat as synonyms. Our federal guide calls the line between them the one examiners love, because a question can describe a defective drug in plain terms and ask you to name which violation it is. A candidate who has filed both words under "bad drug" picks between two answers that look equally right. Learn the line itself from the statute or your study guide, but know that it is drawn on purpose and tested on purpose.

The second is the six controlled substance subtopics under 3.B. Laid out as a list, they look like six separate piles of rules to memorize. Our federal guide opens with a different frame, the Controlled Substances Act's closed system of distribution, and treats the six subtopics as parts of that one system. The details hang together better that way. Learned as six separate lists, they tend to get swapped with each other under time pressure.

Is the Uniform MPJE's federal list different?

Slightly, and the difference is concrete. The Uniform MPJE Content Outline describes the exam as assessing "both state and federal pharmacy laws." Its item 1.D is headed "Federal regulatory standards" and lists NIOSH and OSHA alongside three compounding topics: essential copies of commercial products, patient-specific prescription requirements, and anticipatory compounding. Its item 1.E anchors compounding and hazardous materials to USP standards. Its 3.A.1 also adds the US Department of Health and Human Services (HHS) to the FDA and the DEA as an example of a federal authority.

The state MPJE outline handles the same ground differently. Its 1.E reads "State-specific standards on compounding and hazardous materials", with USP standards listed separately under 1.D. So on the UMPJE, the compounding item is framed through federal and USP standards; on a state MPJE from March 2027, it is headed by your state's standards. The full UMPJE blueprint is in what is on the Uniform MPJE.

Do the federal rules themselves change?

Yes, and the outline names at least one topic where they have moved recently. DSCSA compliance has rolled out in phases, and FDA has issued exemptions along the way. When FDA issued new DSCSA exemptions for small business dispensers in August 2026, our federal guide had to be revised to match.

The same goes for every federal item on the list. "Federal" sounds fixed, and candidates tend to assume that federal material, unlike state rules, can be learned once from any source. It cannot. A prep book printed before a federal change is wrong on that point. For DSCSA, check FDA's current DSCSA waivers, exceptions and exemptions page for status. For controlled substances, the DEA Diversion Control Division website carries the current regulations and a guidance document portal.

What federal topics sit outside the two big statutes?

Most federal prep, ours included, is built on two statutes: the Controlled Substances Act and the FDCA. Our Federal Pharmacy Law: The MPJE Foundation 2026-2027 spends eight chapters on that core, from scheduling and DEA forms through prescriptions, records, the FDCA, restricted OTC products and compounding.

The new outline reaches past that core in a few places: OSHA and NIOSH under regulatory standards, security of patient health information, emergency use authorizations, importation, and PDMP requirements. Some of those are mostly state law in practice, and some sit in federal law outside the two big statutes. If your plan stops at the CSA and the FDCA, put those outline items on a checklist and confirm each one is covered somewhere, in your state guide, your school notes, or the primary source.

A topic map gets you as far as the right chapters and no further. Where federal law fits in a full study schedule is covered in how to study federal pharmacy law, and the wider picture of federal content on the exam is in federal pharmacy law on the MPJE.

FAQ

Does the MPJE test the Controlled Substances Act?

The outline never names the act by title. It does list controlled-substance topics, including inventory, record keeping, order forms and ordering, DEA registration and power of attorney, theft and loss, and disposal. In federal terms, those topics come from the Controlled Substances Act and DEA regulations, so expect to need that law even though NABP does not cite it.

Is HIPAA on the MPJE?

NABP's MPJE Content Outline lists "Security of patient health information" but does not name HIPAA. HIPAA is the obvious federal law behind that topic, and states have their own privacy rules too. Treat it as a tested topic with both a federal and a state layer.

Is there a separate federal pharmacy law exam?

No. NABP's exams are the NAPLEX, the MPJE, the UMPJE and the FPGEE, and none of them is a federal law exam. Federal law is tested inside the MPJE or UMPJE, and only individual state boards of pharmacy issue a license to practice.

Do I need to know which questions are federal?

Not as a label, because the exam does not use one. NABP states that no distinction is made between federal and state questions, and you answer under the prevailing law of the state where you seek licensure. What you need is the ability to tell which layer of law controls a given answer.

Preparing for the federal side of the MPJE? Federal Pharmacy Law: The MPJE Foundation 2026-2027 covers the Controlled Substances Act, the DEA's regulations and the FDCA, with 80+ checkpoint questions and every answer explained. Not sure yet? Try 12 of its questions free and we'll email you the sampler PDF.

Mortar & Law is an independent publisher. MPJE and NABP are trademarks of the National Association of Boards of Pharmacy. CPJE is administered by the California State Board of Pharmacy. Our books are independent study material and are not affiliated with, endorsed by, or sponsored by any of them.

Nothing here is legal advice. Exam and licensure requirements change; verify anything you plan to act on with your state board of pharmacy.